Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
novartis
4
×
biotech
cancer
life sciences
national
national blog main
bristol-myers squibb
cancer immunotherapy
samit hirawat
8vc
abbvie
allergan aesthetics
alzheimer's disease
amgen
articles
astrazeneca
athira pharma
atlantic
attralus
biontech
boehringer ingelheim
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer drugs
chiesi farmaceutici
cholestatic liver diseases
click therapeutics
covid-19
cullinan oncology
cystic fibrosis
daniel o'day
deals
detroit blog main
detroit top stories
diabetic macular edema
diagnostics
disease
dogma therapeutics
What
company’s
4
×
clinical
pipeline
year
acquisition
anniversary
approaches
bn
bristol
celgene
chief
corporation
diversity
hirawat
medical
myers
myers’s
officer
progress
scrip
spoke
squibb
trial
acquisitions
analyze
based
biggest
bio
build
buy
cell
ceo
coming
daniel
debut
detection
developer
diagnostic
doctors
drug
Language
unset
Current search:
novartis
×
company’s
×
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@techcrunch.com
5 years ago
PathAI raises $60 million for its computer vision-based pathogen detection technology
